Allele Biotechnology Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $450K

  • Investors
  • 8

Allele Biotechnology General Information

Description

Developer of cell therapy and regenerative medicine technologies designed to support therapeutic development through cellular reprogramming. The company's platform offers non-integrating cellular reprogramming methods, good manufacturing practice-induced pluripotent stem cell lines, nanobody development, and fluorescent protein technologies, enabling biotechnology companies, pharmaceutical companies, and research institutions to advance cell therapy research and therapeutic development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6404 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 6404 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allele Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Grant 01-Sep-2018 $450K Completed Generating Revenue
8. Later Stage VC (Series A1) 26-Oct-2016 Completed Generating Revenue
7. Grant 14-Sep-2016 Completed Generating Revenue
6. Grant 01-Jan-2015 Completed Generating Revenue
5. Later Stage VC (Series A) 24-Sep-2014 Completed Generating Revenue
4. Grant 01-Jan-2013 Completed Pre-Clinical Trials
3. Grant 01-Jan-2010 Completed Pre-Clinical Trials
2. Grant 01-Jan-2003 $199K Completed Pre-Clinical Trials
1. Grant 01-Jan-2001 $449K Completed Pre-Clinical Trials
To view Allele Biotechnology’s complete valuation and funding history, request access »

Allele Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view Allele Biotechnology’s complete cap table history, request access »

Allele Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell therapy and regenerative medicine technologies designed to support therapeutic development through cel
Biotechnology
San Diego, CA
29 As of 2026

Irvine, CA
 

Noida, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Allele Biotechnology Competitors (29)

One of Allele Biotechnology’s 29 competitors is GeneTex, a Formerly VC-backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneTex Formerly VC-backed Irvine, CA
Allele Life Sciences Private Corporation Noida, India
New England Biolabs Corporation Ipswich, MA
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
Molecular Express Corporation Los Angeles, CA
You’re viewing 5 of 29 competitors. Get the full list »

Allele Biotechnology Patents

Allele Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019170405-A Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna Pending 22-Jul-2019
JP-2024164090-A Method of achieving high specificity of gene editing Pending 13-Jul-2018
CA-3106162-A1 Methods of achieving high specificity of genome editing Pending 13-Jul-2018
EP-3820503-A1 Methods of achieving high specificity of genome editing Pending 13-Jul-2018
EP-3820503-A4 Methods of achieving high specificity of genome editing Pending 13-Jul-2018 C12N15/102
To view Allele Biotechnology’s complete patent history, request access »

Allele Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allele Biotechnology Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
TriAnchor Capital Group PE/Buyout Minority
National Institute of General Medical Sciences Government
National Institute on Aging Government
Tsing-Yuan Capital Venture Capital Minority
Yifang Technology Group Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Allele Biotechnology FAQs

  • When was Allele Biotechnology founded?

    Allele Biotechnology was founded in 1999.

  • Where is Allele Biotechnology headquartered?

    Allele Biotechnology is headquartered in San Diego, CA.

  • What is the size of Allele Biotechnology?

    Allele Biotechnology has 29 total employees.

  • What industry is Allele Biotechnology in?

    Allele Biotechnology’s primary industry is Biotechnology.

  • Is Allele Biotechnology a private or public company?

    Allele Biotechnology is a Private company.

  • What is Allele Biotechnology’s current revenue?

    The current revenue for Allele Biotechnology is .

  • How much funding has Allele Biotechnology raised over time?

    Allele Biotechnology has raised $18M.

  • Who are Allele Biotechnology’s investors?

    TriAnchor Capital Group, National Institute of General Medical Sciences, National Institute on Aging, Tsing-Yuan Capital, and Yifang Technology Group are 5 of 8 investors who have invested in Allele Biotechnology.

  • Who are Allele Biotechnology’s competitors?

    GeneTex, Allele Life Sciences Private, New England Biolabs, Abcam, and Molecular Express are some of the 29 competitors of Allele Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process